- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Ted Mikuls Discusses Gout Interventions to Prevent Amputation
Ted Mikuls, MD, MSPH, Stokes-Shackleford professor of rheumatology, vice chair for research, internal medicine at the University of Nebraska, discusses interventions and treatments that could prevent lower extremity amputation for people with gout.
Ted Mikuls, MD, MSPH, Stokes-Shackleford professor of rheumatology, vice chair for research, internal medicine at the University of Nebraska, led a study that showed that heightened foot care and surveillance may have led to the lower rate of lower extremity amputation (LEA) among people with diabetes. Here, he explains how interventions and treatments could prevent LEA for people with gout, and that people being considered for LEA may not know they have gout.
Transcript
Are there standards of care that people with gout but without diabetes need to prevent lower extremity amputation?
There really aren't standards in terms of what should be done with someone with gout without diabetes in terms of a frequency of a foot exam and such. I think the main message is that, for patients who are being considered for lower extremity amputation—and that's often people who have non-healing wounds on their feet, may have suspected osteomyelitis or deep infection of the bone or soft tissues of the foot, or even other places of lower extremity—I think for those patients, this study maybe should make providers take pause. Ask yourself the question: could this patient have gout? Could gout intervention or gout treatment make a difference for this patient? I think if you take time to answer those questions and you're definitive in your questions, a patient's going to be better off in the end and I think that's the take home.
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
Polypharmacy Common in Rheumatoid Arthritis, Driving Risk of Serious Drug Interactions
August 13th 2025More than 8 in 10 patients with rheumatoid arthritis were taking 5 or more medications at once, a practice linked to older age, multiple comorbidities, and more than 2000 potential drug-to-drug interactions.
Read More
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Accessing pediatric dermatology care is challenging due to a shortage of specialists and general dermatologists' reluctance to treat children, but increasing their comfort level with seeing children could help bridge the gap, explained Elizabeth Garcia Creighton, of University of Colorado School of Medicine.
Read More
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
